As advised via PHARMAC tender of 30 April 2018 there is to be a change in the listing and future sole supply.

New listings- from 1 July 2018 (HML only)

Tranexamic-AFT Inj 100 mg per ml, 5 ml 5 ampoules                                                   Pharmacode 2497166          Schedule price $6.95

Incumbent brand

Cyklokapron Inj 100 mg per ml, 5 ml 10                                                                                       Pharmacode 680974         Schedule price $55.00

Reference pricing will not apply to the incumbent which will be delisted 1 September 2018.

As of the date of this notification ProPharma / PWR cannot accept Cyklokapron Injection for credit under any circumstances.

We would recommend you continue to purchase the incumbent and we will change automatically as existing stocks are exhausted.

Once again we need your support to ensure stock in the supply chain moves through to effectively ensure no losses are incurred.

Together we can make this a seamless and painless transition.

We thank you in anticipation of your ongoing support.


About The Author